Investigation of Gastric Emptying by Gastric Ultrasonography in Diabetic Patients Treated With GLP-1 Receptors
Recruiting
Observational Study
Diabete Type 2
Regurgitation
Pulmonary Aspiration During Anaesthetic Induction
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 38 (estimated)
- Sponsor
- University Hospital, Geneva · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Treatment with semaglutide slows down gastric emptying , food remains in the stomach for a longer period of time. This slowing has important implications for anesthesia management. At present, we do not know the optimal duration for discontinuing this medication before surgery and anesthesia to ensure an empty stomach.
This is an observational research project, conducted exclusively at the Geneva…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Female/ Male of 18 years old or more
* With Type 2 Diabetes
* Treated with GLP 1 analog for more than 3 months
* Signed consent
* ASA between I and IV
Exclusion Criteria:
* Insuline treatment
* Gastro intestinal motility disorders
* Past gastric surgery
* Hiatal hernia
* Rec…
Contacts
No contact information available.